Letter to the Editor: Evaluation of the Incidence, Severity, and Mortality Rate of COVID-19 in Patients with Multiple Sclerosis Receiving Interferon β-1a

Naser Moghadasi ، Abdorreza Multiple Sclerosis Research Center, Neuroscience Institute - Tehran University of Medical Sciences , Anjidani ، Nassim Medical Department - Orchid Pharmed Company

1

2

Advanced Journal of Emergency Medicine

Advanced Journal of Emergency Medicine

2738028